News und Analysen

The pharmaceutical industry has been a source of extraordinary returns for investors who have picked the right stocks. Since the end of World War II, five of the top 30 performers in the U.S. stock

CRISPR Therapeutics (NASDAQ: CRSP) has reached a very important chapter in its growth story. The gene-editing specialist doesn't have products on the market right now, but that could change in just

It's been about a couple of weeks since Pfizer (NYSE: PFE) promised to make Halloween extra spooky by warning us that third-quarter results would be disappointing. 

It turns out the warning was more

Image source: The Motley Fool.

Pfizer (NYSE: PFE)Q3 2023 Earnings CallOct 31, 2023, 10:00 a.m. ET

Operator

Continue reading

Source Fool.com

On Oct. 13, regulators at the Food and Drug Administration (FDA) ruled that Pfizer's (NYSE: PFE) new drug for moderate to severe ulcerative colitis (UC), Velsipity, was ready for prime time. That

There are many things you can buy with $1,000, but most won't multiply your wealth over time. Investing in equity markets remains one of the best options. Buying shares of great companies and

One thing income seekers don't want to see from the businesses they invest in is a major disruption to their incoming cash flows. Unfortunately for shareholders of AbbVie (NYSE: ABBV), the

As you may have heard, Novo Nordisk (NYSE: NVO) makes Ozempic, the type 2 diabetes medication sweeping the globe and raking in billions in the process. Where there's a money-printing drug in ascent

Pharmaceutical company AbbVie (NYSE: ABBV) was a cure for the investor blues on Monday. Shares of the company rose more than 2% in price on an analyst's recommendation upgrade. AbbVie stock's

Shares of Revvity (NYSE: RVTY) -- formerly known as PerkinElmer -- fell 16.1% on Monday after the health science solutions and services company announced weaker-than-expected third-quarter 2023

Dividend stocks can be consistent market-beaters. However, empirical research shows that the best dividend stocks tend to generate better-than-average returns because of their underlying value

Sometimes, the old financial adages are spot on. For example, it does take money to make money. And the expression that "time is money" is correct in many ways.

But it's also true that some

Shares of AbbVie (NYSE: ABBV) were down 5.4% as of 2:00 p.m. ET Friday, even after the pharmaceuticals giant announced slightly better-than-expected quarterly results and raised its full-year

Image source: The Motley Fool.

AbbVie (NYSE: ABBV)Q3 2023 Earnings CallOct 27, 2023, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

If you want to beat the market, the key is having strong stocks in your portfolio of businesses that are profitable and growing. One name that has routinely outperformed the markets is health

The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities

While equity markets this year have recovered some of ground lost from the plunge of 2022, plenty of companies are still struggling. Some of them, though, clearly have the tools to rebound

It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). Shares of all three healthcare companies are trading flat or down amid

Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed in the double digits this year and is trading around its highest ever. There are plenty of reasons for this top performance. The company continues

It hasn't been the easiest time for investors across a range of industries and sectors over the last few years. The good news is that when you're buying stocks to hold onto for anywhere from five

Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and

Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors

Did you know that if you have a high-yielding dividend stock that pays 5%, investing just $20,000 would be enough to generate $1,000 in annual dividend income? High-yielding stocks can be extremely

BioNTech (NASDAQ: BNTX) is the lesser-known member of the pair -- which also includes Pfizer -- that developed and marketed Comirnaty, one of the leading coronavirus vaccines on the market. However